https://www.selleckchem.com/pr....oducts/paeoniflorin.
Flow cytometric crossmatch assay (FCXM) is a sensitive cell-based method for evaluating the presence of donor-specific antibodies (DSA) before transplantation. Recently, 96-well tray FCXM protocol (Halifax FCXM) with improved test efficiency has been introduced. The objective of the present study was to assess the performance of Halifax FCXM by correlating with DSA results based on single antigen bead (SA assays (virtual crossmatch, VXM). A total of 341 FCXMs were evaluated for the detection of HLA-DSA. A positive VXM was defined